Enveric Biosciences, Inc. (ENVB)

NASDAQ: ENVB · IEX Real-Time Price · USD

0.934

+0.037 (4.08%)

At close: Apr 24, 2024, 4:00 PM

0.913

-0.022 (-2.30%)

After-hours: Apr 24, 2024, 6:14 PM EDT

Enveric Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	-17.46	-18.8	-48.98	-6.86	-2.41	-19.48	-11.16	-2.78	-0.81
Depreciation & Amortization	0.41	0.44	0.68	0.12	0	2.9	3.22	1.36	0.17
Share-Based Compensation	2.15	2.62	12.6	1.98	0.62	1.25	7.08	1.46	0.14
Other Operating Activities	0.64	-1.73	24.24	0.88	1.14	10.18	-3.96	-2.74	-0.49
Operating Cash Flow	-14.09	-17.15	-11.46	-3.89	-0.65	-2.57	-2.74	-2.7	-1
Capital Expenditures	0.01	-0.58	-0.19	0	0	0.01	-0	-0.03	-0.07
Acquisitions	0	0	2.38	0	0	-3.65	-0.17	-6.56	-4.67
Other Investing Activities	-	-	-	-0.04	-	-	-	-	-
Investing Cash Flow	0.01	-0.58	2.19	-0.04	0	-3.64	-0.17	-6.59	-4.74
Share Issuance / Repurchase	0	17.22	24.9	3.86	0	6.33	4.9	5	0
Debt Issued / Paid	0	0	0	1.67	0.56	-1.98	2.15	3.79	6.24
Other Financing Activities	-1.34	0.96	-	-	-	-1.66	-0.64	0	-
Financing Cash Flow	-1.34	18.18	24.9	5.53	0.56	2.69	6.41	8.8	6.24
Exchange Rate Effect	-0.01	-0.08	0.14	-0.06	0.02	0	0	0	0
Net Cash Flow	-15.44	0.37	15.78	1.53	-0.07	-3.51	3.5	-0.5	0.5
Free Cash Flow	-14.08	-17.73	-11.65	-3.89	-0.65	-2.56	-2.75	-2.73	-1.07
Free Cash Flow Margin	-	-	-	-	-	-5.95%	-5.65%	-7.56%	-5.28%
Free Cash Flow Per Share	-6.52	-12.26	-24.66	-33.79	-6.13	-537.85	-916.26	-1045.66	-481.46

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).